Metrohm UK has announced that on 14 September it will be moving its UK headquarters to new purpose built facilities in Runcorn, Cheshire, UK.
Metrohm UK has announced that on 14 September it will be moving its UK headquarters to new purpose built facilities in Runcorn, Cheshire, UK.
According to the company the state of the art premises will be a hub for its UK business and will have a high focus on facilities for customers and staff. These facilities are reported to include several applications labs and customer demonstration areas, as well as training facilities, seminar rooms and service and warehousing areas.
The company is inviting customers to an Open Day and more information about that is available by e-mailing [email protected]
From 14 September the company’s new address is:
Metrohm UK Ltd
Metrohm House, Evenwood Close,
Daresbury Court,
Runcorn,
Cheshire
WA7 1LZ
Tel. +44 1928 579600
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
LC/MS Based Characterization Workflow of GLP-1 Therapeutic Peptide Liraglutide and Its Impurities
January 14th 2025This application note demonstrates a liquid chromatography/quadrupole time-of-flight mass spectrometer (LC/Q-TOF MS) workflow for the identification and characterization of therapeutic peptides.